Ledger.Open graph →
SEC Form D · filed January 2, 2019

FLX Bio, Inc

Offering
$35.0M
Sold
$22.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

David V. Goeddel · South San Francisco, CADirectorBrian Wong · South San Francisco, CAExec · DirectorWilliam J. Rieflin · South San Francisco, CADirectorBeth V. Seidenberg · South San Francisco, CADirectorLinda J. Kozick · South San Francisco, CADirectorMichael F. Giordano · South San Francisco, CADirectorRekha J. Hemrajani · South San Francisco, CAExecDavid V. Goeddel · South San Francisco, CADirectorBrian Wong · San Francisco, CAExec · DirectorWilliam J. Rieflin · Santa Clara, CADirectorBeth V. Seidenberg · South San Francisco, CADirectorLinda J. Kozick · South San Francisco, CADirectorMichael F. Giordano · South San Francisco, CADirectorRekha J. Hemrajani · South San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗